Chronic kidney disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients undergoing maintenance haemodialysis who are currently admitted to Hidaka Rehabilitation Hospital, Hidaka Medical Corporation 2) Patients who are adults (in principle, aged 18 years or over) at the time of study enrolment 3) Patients who are able to sit independently and who can undergo IMT and respiratory function tests whilst understanding instructions 4) Patients who have been undergoing dialysis for at least three months 5) Patients from whom written informed consent has been obtained regarding participation in the study
Exclusion criteria
Exclusion criteria: 1) Patients in the acute phase of serious heart conditions, such as acute heart failure or acute coronary syndrome 2) Patients with traumatic pneumothorax or rib fractures that have not fully healed 3) Patients with asthma that frequently relapses 4) Patients with injuries such as a perforated eardrum 5) Patients with a marked increase in left ventricular end-diastolic volume and left ventricular end-diastolic pressure 6) Patients with abdominal hernias 7) Patients who have developed pneumonia or an acute respiratory infection within the last four weeks and whose condition is not stable 8) Patients who have difficulty understanding instructions or coughing safely due to severe cognitive impairment or dysphagia 9) Other patients deemed unsuitable for participation in this study by the principal investigator or a co-investigator [Rationale for Exclusion Criteria] 1) to 7) From a safety perspective, as these patients are considered to be at high risk of deterioration due to the intervention or measurements. 8) As compliance with measurement and intervention procedures is difficult, which may affect data reliability and safety. 9) To rule out the possibility that participation in the study may be detrimental, based on individual medical judgement.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint is an analysis of the difference in changes in cough force (PCF) between the IMT intervention group and the sham group in patients with HD. | — |
Countries
Japan
Contacts
Hidaka Rehabilitation Hospital Plastic Surgery